U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 019710

Expand all

OPTIRAY 300 (IOVERSOL)
64%
Marketing Status: Prescription
Active Ingredient: IOVERSOL
Proprietary Name: OPTIRAY 300
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 64%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N019710
Product Number: 004
Approval Date: Jan 22, 1992
Applicant Holder Full Name: LIEBEL-FLARSHEIM CO LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
OPTIRAY 320 (IOVERSOL)
68%
Marketing Status: Prescription
Active Ingredient: IOVERSOL
Proprietary Name: OPTIRAY 320
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 68%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N019710
Product Number: 001
Approval Date: Dec 30, 1988
Applicant Holder Full Name: LIEBEL-FLARSHEIM CO LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
OPTIRAY 350 (IOVERSOL)
74%
Marketing Status: Prescription
Active Ingredient: IOVERSOL
Proprietary Name: OPTIRAY 350
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 74%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N019710
Product Number: 005
Approval Date: Jan 22, 1992
Applicant Holder Full Name: LIEBEL-FLARSHEIM CO LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
OPTIRAY 160 (IOVERSOL)
34%
Marketing Status: Discontinued
Active Ingredient: IOVERSOL
Proprietary Name: OPTIRAY 160
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 34%
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019710
Product Number: 003
Approval Date: Dec 30, 1988
Applicant Holder Full Name: LIEBEL-FLARSHEIM CO LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information
OPTIRAY 240 (IOVERSOL)
51%
Marketing Status: Discontinued
Active Ingredient: IOVERSOL
Proprietary Name: OPTIRAY 240
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 51%
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N019710
Product Number: 002
Approval Date: Dec 30, 1988
Applicant Holder Full Name: LIEBEL-FLARSHEIM CO LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top